Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2028841000168111 | sebelipase alfa 2 mg / 1 mL injection, 1 x 1 mL vial (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2028851000168113 | sebelipase alfa 2 mg/mL injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sebelipase alfa 2 mg/mL injection, 1 mL vial | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| sebelipase alfa 2 mg/mL injection, 1 mL vial | has MPUU | sebelipase alfa 2 mg/mL injection, vial | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Kanuma (sebelipase alfa 2 mg / 1 mL) injection solution, 1 x 1 mL vial (trade product pack) | Is a | False | sebelipase alfa 2 mg/mL injection, 1 mL vial | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR